
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Lucinda Maine, PhD, RPh, Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP), discusses how emerging trends in health care could impact pharmacists and their practice.
Lucinda Maine, PhD, RPh, Executive Vice President and CEO of the American Association of Colleges of Pharmacy (AACP), discusses how emerging trends in health care could impact pharmacists and their practice.






